FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Eisai Belviq¿ Recall

BELVIQ¿ (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Are…

Eisai Inc · Research Triangle Park, NC

Risk level
Class III
Reported by FDA
Dec 24, 2014
Recall ID
D-0302-2015
Check your lot numberHow we source this data

Summary

Eisai recalled Belviq¿ starting Dec 5, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0302-2015 on Dec 24, 2014. Reason: Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date. Status: Terminated.

Why it was recalled

Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.

Product description

BELVIQ¿ (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena Pharmaceuticals, GmbH, Zofingen, Switzerland, Distributed by: Elsai Inc., Woodcliff, NJ 07677 NDC 62856-52960.

Lot numbers, UPCs & expiration codes

Lot #13297008, Exp. 11/15;13307008, Exp. 11/15;13367008, Exp.12/15.

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0302-2015
Classification
Class III
Status
Terminated
Recall initiated
Dec 5, 2014
FDA report date
Dec 24, 2014
Quantity
121,680 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Eisai Inc

Original FDA data

Every field from FDA enforcement report D-0302-2015, exactly as published.

Show all FDA fields
City
Research Triangle Park
State
NC
Status
Terminated
Country
United States
Event ID
69959
Address
900 Davis Drive
Code information
Lot #13297008, Exp. 11/15;13307008, Exp. 11/15;13367008, Exp.12/15.
Postal code
27709
Report date
Dec 24, 2014
Product type
Drugs
Recall number
D-0302-2015
Classification
Class III
Recalling firm
Eisai Inc
Product quantity
121,680 bottles
Termination date
May 21, 2015
Reason for recall
Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.
Voluntary / mandated
Voluntary: Firm initiated
Product description
BELVIQ¿ (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena Pharmaceuticals, GmbH, Zofingen, Switzerland, Distributed by: Elsai Inc., Woodcliff, NJ 07677 NDC 62856-52960.
Distribution pattern
Nationwide.
Recall initiation date
Dec 5, 2014
Initial firm notification
Letter
Center classification date
Dec 16, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0302-2015, published Dec 24, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls